Search Results

1 - 10 of 13 items :

  • "peripheral nerve sheath tumors" x
Clear All
Immunohistochemical Distinguishing between Canine Peripheral Nerve Sheath Tumors and Perivascular Wall Tumors

. Vet Pathol 2004, 41(4):307-318. 4. Ramires GA, Herraez P, Rodrigues F, Godhino A, Andrada M, Espinosa de los Monteros A: Malignant peripheral nerve sheath tumor (malignant Schwannoma) in the diaphragm of a goat. J Comp Pathol 2007, 137:137-141. 5. Schulman FY, Johnson TO, Facemire PR: Feline peripheral nerve sheath tumors: histologic, immunohistochemical, and clinicopathologic correlation (59 tumors in 53 cats). Vet Pathol 2009, 46(6):1166-1180. 6. Kegler K, Mundle K, Walliser U, Wohsein P: Primary intraparotid peripheral nerve sheath tumour with

Open access
Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management

, Thomas JM. Malignant peripheral nerve sheath tumours associated with von Recklinghausen’s neurofibromatosis. Eur J Surg Oncol 1999; 25: 190-3. 4. Shimizu J, Arano Y, Murata T, Ishikawa N, Yachi T, Nomura T, et al. A case of intrathoracic giant malignant peripheral nerve sheath tumor in neurofibromatosis type I (von Recklinghausen’s disease). Ann Thorac Cardiovasc Surg 2008; 14: 42-7. 5. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival

Open access
Giant malignant peripheral nerve sheath tumors of the occipital scalp

nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours. Virchows Arch. 1995; 427: 19-26. 17. Kar M, Deo SV, Shukla NK, Malik A, DattaGupta S, Mohanti BK, et al. Malignant peripheral nerve sheath tumors (MPNST)-clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol. 2006; 4:55. 18. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg. 2009; 249

Open access
Reclassification of 21 Presumptive Canine Peripheral Nerve Sheath Tumors (PNST) Using a Literature-Based Immunohistochemical Panel

: Blackwell Science Ltd; 2005, 786-796. 5. Piña-Oviedo S, Ortiz-Hidalgo C. The normal and neoplastic perineurium. Adv Anat Pathol 2008, 15:147-164. 6. Bergmann W, Burgener IA, Roccabianca P, Rytz U, Welle M.: Primary splenic peripheral nerve sheath tumour in a dog. J Comp Pathol 2009, 141:195-198. 7. Brehm DM, Vite CH, Steinberg HS, Haviland J, van Winkle T: A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J Am Anim Hosp Assoc 1995, 31:349-359. 8. Park JW, Woo GH, Jee H, Jung

Open access
Complex Multidisciplinary Follow-Up Of Children With Neurofibromatosis Type 1

peripheral nerve sheath tumours in Neurofibromatosis 1. J Med Genet 2002;39:311-4 [10] Feldmann R, Denecke J, Grenzebach M, Schuierer G, We-glage. Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities. J Neurology. 2003; Dec 23;61(12):1725-8. [11] Ferner R, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A. Guidelines for the diagnosis and management of individuals with Neurofibromatosis 1. J Med Genet. 2007;44(2):81-88. [12] Friedman JM. Neurofibromatosis 1: clinical

Open access
Extensive Peculiar Cutaneous Form of Neurofibromatosis Type I as a New Mutation - a Case Report

spectrum, management, and results. J Vasc Surg 2007;46(3):475–84. 32. Duong TA, Sbidian E, Valeyrie-Allanore L, Vialette C, Ferkal S, Hadj-Rabia S, et al. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France. Orphanet J Rare Dis 2011;6:18. 33. Park SJ, Sawitzki B, Kluwe L, Mautner V, Holtkamp N, Kurtz A. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med 2013;11:109. 34. Karajannis MA, Ferner RE. Neurofibromatosis–related tumors: emerging

Open access
Effectiveness of low-field magnetic resonance imaging in diagnosing brachial plexus tumours in dogs – short communication

References 1. Brehm F., Landi A., DeSantis G., Maiorana A., Canossi G., Romagnoli R.: MR of bening peripheral nervesheath tumors. J Comput Assist Tomogr 1991, 15, 593-597. 2. Brehm D.M., Vite C.H., Steinberg H.S., Haviland J., Van Winkle T.: A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J Am Anim Hosp Assoc 1995, 31, 349-359. 3. Brehm F., Matiasek K., Schmahl W., Waibl H., Brunnberg L.: Peripheral nerve diseases. Part III. Peripheral nerve tumors in dogs and cats: a

Open access
Expression Of Cytokeratin 18 In The Peripheral Nerves

. Hirose, T., Scheithauer, B. W., Sano, T., 1998: Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. Am. J. Surg. Pathol., 22, 1368-1378. 11. Hirose, T., Tani, T., Shimada, T., Ishizawa, K., Shimada, S., Sano, T., 2003: Immunohistochemical demonstration of EMA/ Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod. Pathol.,16, 293-298. 12. Jahn, L., Fouquet, B., Rohe, K., Franke, W. W., 1987

Open access
Role of Fine Needle Aspiration Cytology in the Diagnosis of Skin and Superficial Soft Tissue Lesions: A Study of 510 Cases / Deri ve Yüzeyel Yumuşak Doku Lezyonlarının Tanısında İnce İğne Aspirasyon Sitolojisinin Rolü: 510 Olgunun İncelenmesi

Delhi: Elsevier Limited; 2005. 395. 7. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: Immunohistochemical distinction from primitive neuroectodermal tumors and highgrade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998;22:673-82. 8. Måns Åkerman. Benign and malignant soft tissue tumors. In: Gray W, McKee GT editors. Diagnostic cytopathology. 2nd ed. London, UK: Churchill Livingstone; 2003. 907-8. 9. Wong NL, Dl F. Fine needle aspiration cytology of myxoid lesions of soft

Open access
Clinical manifestations of neurofibromatosis type 1 – a diagnostic and management challenge

Central PMCID: PMC3652086. 7. Messiaen L, Vogt J, Bengesser K, et al. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat. 2011;32:213-9. 8. Ostendorf AP, Gutmann DH, Weisenberg JL. Epilepsy in individuals with neurofibromatosis type I. Epilepsia. 2013;54:1810-4. 9. Zehou O, Fabre E, Zelek L, et al. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review. Orphanet J Rare. 2013;8:127. 10. Burnichon N, Buffet

Open access